Can lifestyle changes reduce HER2-negative BC recurrence?

Hello,

Welcome to icliniq.com.

I understand your concern.

I am sorry to hear about your sister's diagnosis. HER2-negative breast cancer is a subtype of breast cancer that does not overexpress the HER2 protein, which can affect treatment options and outcomes. Treatment options for HER2-negative breast cancer include the following:

Hormone therapy includes treatment for ER or PR-positive breast cancer. If your sister's cancer is also estrogen receptor (ER) or progesterone receptor (PR) positive, hormone therapy is often a key part of treatment.

This can include medications like Tamoxifen, as it blocks estrogen receptors on breast cancer cells. Aromatase inhibitors (such as Anastrozole, Letrozole, Exemestane) reduce the amount of estrogen produced in postmenopausal women. These treatments are often used for several years after initial treatment to reduce the risk of recurrence.

Chemotherapy:

1. Triple-negative breast cancer (TNBC): If her cancer is also ER-negative and PR-negative (known as triple-negative breast cancer), chemotherapy becomes more central.

2. Chemotherapy regimens may include drugs like Anthracyclines (Doxorubicin), Taxanes (Paclitaxel, Docetaxel), and platinum-based chemotherapy (Carboplatin, Cisplatin) for specific cases.

Surgery such as lumpectomy (removal of the tumor and a margin of surrounding tissue, often followed by radiation), or mastectomy (removal of the entire breast). Depending on the stage and size of the tumor, a mastectomy may be recommended.

Radiation therapy is typically recommended after a lumpectomy and sometimes after a mastectomy to reduce the risk of local recurrence.

Targeted therapy:

1. PARP Inhibitors (Olaparib, Talazoparib): For certain patients with triple-negative breast cancer who also have BRCA mutations, PARP inhibitors may be used as part of treatment.

2. Immunotherapy (Pembrolizumab): Approved for some patients with metastatic triple-negative breast cancer, especially if the tumor expresses PD-L1 (programmed death-ligand 1).

About recent advancements, there are two main lines of treatment:

1. Immunotherapy: The combination of immunotherapy with chemotherapy has shown promise in treating advanced triple-negative breast cancer.

2. CDK4/6 inhibitors (Palbociclib, Ribociclib, Abemaciclib): These have shown efficacy in hormone receptor-positive, HER2-negative breast cancer, particularly in metastatic (process by which cancer cells spread from the original (primary) site to other parts of the body) cases.

The likelihood of recurrence varies based on the stage at diagnosis, tumor size, and whether lymph nodes are involved. Triple-negative breast cancer has a higher risk of recurrence, especially in the first few years after treatment.

To reduce the recurrence risk, one must make sure:

1. She completes her prescribed hormone therapy, chemotherapy, or other treatments.

2. To follow a healthy diet, exercise, maintain a healthy weight, and avoid alcohol.

3. Regular check-ups and imaging tests should be done as recommended by her oncologist.

Indeed, lifestyle changes or supportive therapies can improve her outlook. They include:

1. Regular physical activity has been shown to improve outcomes in breast cancer survivors.

2. A diet rich in fruits, vegetables, whole grains, and lean proteins, with limited processed foods and red meats, can support overall health.

3. Stress management techniques like yoga, meditation, or counseling can help manage the emotional impact of cancer and its treatment.

4. Connecting with others who are going through similar experiences can provide emotional support and practical advice.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.